MENU
Advertisement
With commentary from Michael P. Thompson, PhD
Reprints
View Supplement
COAPT 5-Year Data Demonstrate Benefits of Mitral TEER, Reveal Need to Address Underlying LV Dysfunction
With commentary from Gregg Stone, MD
left-arrow Created with Sketch. Previous Article
Renal Denervation: Where We Stand After the FDA Panels
With Ajay J. Kirtane, MD, SM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM; and Taisei Kobayashi, MD
Next Article right-arrow Created with Sketch.
Modern Clinical Trials Spotlight
Insights on current trial designs, inclusivity, and next steps.
View Issue
enVast™: Engineered for Coronary Thrombectomy
By Marco Valgimigli, MD, PhD
AeroShield™ Elite: Passive Protection Without Compromise
By William Gray, MD
Operationalizing Radiation Safety in Cardiovascular Programs
By Denise Busman, MSN, RN, CPHQ, FACC
Modern Valve Intervention Workflows: Maintaining Efficiency Across Applications and Indications
With Mazen Albaghdadi, MD, MSc, and Natalia C. Berry, MD, MBA
Contemporary Strategies in Minimalist TAVR
With Yousif Ahmad, MBBS, PhD, FACC, FSCAI; Tara L. Jones, MD, PharmD; Dhaval S. Kolte, MD, MPH, PhD, FACC, FSCAI; and John T. Saxon, MD